David D Chang - Net Worth and Insider Trading
David D Chang Net Worth
The estimated net worth of David D Chang is at least $25 Million dollars as of 2024-11-13. David D Chang is the President and CEO of Allogene Therapeutics Inc and owns about 5,202,848 shares of Allogene Therapeutics Inc (ALLO) stock worth over $15 Million. David D Chang is also the EVP, R&D, Chief Medical Off. of Kite Pharma Inc and owns about 57,423 shares of Kite Pharma Inc (KITE) stock worth over $10 Million. Details can be seen in David D Chang's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that David D Chang has not made any transactions after 2022-03-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of David D Chang
David D Chang Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, David D Chang owns 2 companies in total, including Allogene Therapeutics Inc (ALLO) , and Kite Pharma Inc (KITE) .
Click here to see the complete history of David D Chang’s form 4 insider trades.
Insider Ownership Summary of David D Chang
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ALLO | Allogene Therapeutics Inc | 2022-03-15 | director & President and CEO |
| KITE | Kite Pharma Inc | 2017-10-03 | EVP & R&D & Chief Medical Off. |
David D Chang Latest Holdings Summary
David D Chang currently owns a total of 2 stocks. Among these stocks, David D Chang owns 5,202,848 shares of Allogene Therapeutics Inc (ALLO) as of March 15, 2022, with a value of $15 Million and a weighting of 58.87%. David D Chang also owns 57,423 shares of Kite Pharma Inc (KITE) as of September 25, 2017, with a value of $10 Million and a weighting of 41.13%.
Latest Holdings of David D Chang
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ALLO | Allogene Therapeutics Inc | 2022-03-15 | 5,202,848 | 2.84 | 14,776,088 |
| KITE | Kite Pharma Inc | 2017-09-25 | 57,423 | 179.79 | 10,324,081 |
Holding Weightings of David D Chang
David D Chang Form 4 Trading Tracker
According to the SEC Form 4 filings, David D Chang has made a total of 3 transactions in Allogene Therapeutics Inc (ALLO) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Allogene Therapeutics Inc is the sale of 23,648 shares on March 15, 2022, which brought David D Chang around $180,907.
According to the SEC Form 4 filings, David D Chang has made a total of 0 transactions in Kite Pharma Inc (KITE) over the past 5 years. The most-recent trade in Kite Pharma Inc is the sale of 7,927 shares on September 25, 2017, which brought David D Chang around $1 Million.
Insider Trading History of David D Chang
- 1
David D Chang Trading Performance
GuruFocus tracks the stock performance after each of David D Chang's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by David D Chang is 3.67%. GuruFocus also compares David D Chang's trading performance to market benchmark return within the same time period. The performance of stocks bought by David D Chang within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how David D Chang's insider trading performs compared to the benchmark.
Performance of David D Chang
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -0.11 | | | | | |
| Relative Return to S&P 500(%) | 0.64 | | | | | |
David D Chang Ownership Network
Ownership Network List of David D Chang
Ownership Network Relation of David D Chang
David D Chang Owned Company Details
What does Allogene Therapeutics Inc do?
Who are the key executives at Allogene Therapeutics Inc?
David D Chang is the director & President and CEO of Allogene Therapeutics Inc. Other key executives at Allogene Therapeutics Inc include director & 10 percent owner Arie Belldegrun , CHIEF FINANCIAL OFFICER Geoffrey M. Parker , and GENERAL COUNSEL Earl Martin Douglas .
Allogene Therapeutics Inc (ALLO) Insider Trades Summary
Over the past 18 months, David D Chang made no insider transaction in Allogene Therapeutics Inc (ALLO). Other recent insider transactions involving Allogene Therapeutics Inc (ALLO) include a net sale of 37,281 shares made by Deborah M. Messemer , a net purchase of 1,724,137 shares made by Arie Belldegrun , and a net sale of 11,200 shares made by Franz B Humer .
In summary, during the past 3 months, insiders sold 0 shares of Allogene Therapeutics Inc (ALLO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 58,481 shares of Allogene Therapeutics Inc (ALLO) were sold and 1,724,327 shares were bought by its insiders, resulting in a net purchase of 1,665,846 shares.
Allogene Therapeutics Inc (ALLO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Allogene Therapeutics Inc Insider Transactions
David D Chang Mailing Address
Above is the net worth, insider trading, and ownership report for David D Chang. You might contact David D Chang via mailing address: C/o Allogene Therapeutics, Inc., 210 East Grand Avenue, South San Francisco Ca 94080.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
